Registry and biorepository for patients with inflammatory bowel diseases in Central Texas
Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas
This study is trying to create a database and collection of samples from people with inflammatory bowel diseases like Crohn's and ulcerative colitis to help future research on these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Austin, Texas) |
| Trial ID | NCT04617184 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a registry and biorepository for patients diagnosed with inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. It involves the prospective collection of clinical data and biological samples, including blood, tissue, and fecal samples, during routine medical procedures. Participants will provide consent to share their health information and samples, which will be used for future research on IBD. The study will follow patients longitudinally, gathering data from both the patients and their gastroenterologists.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with known or suspected inflammatory bowel disease who can provide informed consent.
Not a fit: Patients who are unable to comprehend or cooperate with study activities or those too ill to provide consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of inflammatory bowel diseases and lead to improved treatment strategies.
How similar studies have performed: Other studies utilizing registries and biorepositories for chronic diseases have shown success in advancing research and treatment options.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, age 18 years or older * Willing and able to provide written consent for participation in the registry and biorepository * Patients with known or suspected inflammatory bowel disease Exclusion Criteria: * Patient is unable to comprehend and/or cooperate with study activities * Patient is too ill to provide consent * Coagulopathy that precludes safe biopsy of the bowel * Comorbidity that precludes safe participation in endoscopic procedures
Where this trial is running
Austin, Texas
- Dell Medical School, UT Austin — Austin, Texas, United States (Recruiting)
Study contacts
- Study coordinator: Benjamin Chebaa, BA
- Email: benjamin.chebaa@austin.utexas.edu
- Phone: 5124955641
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.